Metformina Galenicum 850 mg comprimidos recubiertos con película EFG clinical trials

Randomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progression in Huntington's disease patients.

This study is looking at whether a common diabetes medicine called metformin could help people with Huntington's disease with their thinking and memory. It compares metformin to a dummy pill to see if it makes a difference to how the disease progresses.